ArticleInternational urogynecology journal2025
Turkish Validation and Reliability Analysis of the International Female Coital Incontinence Questionnaire.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisCoital incontinence (CI) is an important problem that negatively affects women's quality of life and is often underreported owing to embarrassment, indicating the importance of its assessment with validated questionnaires. The aim of this study was to validate the Turkish-translated version of the International Female Coital Incontinence Questionnaire (IFCI-Q) for the objective evaluation of women with CI in Turkish-speaking populations.
methodsNinety women with CI filled out the Turkish-translated version of IFCI-Q. Confirmatory factor analysis (CFA), Cronbach's alpha, and intraclass correlation coefficients (ICCs) were evaluated for the construct validity, internal consistency, and test-retest reliability, respectively. Known group validity, which is the ability of the scale to reveal the expected difference according to patients' demographics and PISQ-12 scores, was evaluated.
resultsThe construct validity was confirmed after excluding the first and third items of the questionnaire (CFI 0.966, TLI 0.944). The first item was excluded from the CFA as all women who completed the IFCI-Q had CI and therefore answered this item questioning the existence of CI as "yes." The third item was eliminated because its factor loading was below 0.20. Cronbach's alpha value for the scale was 0.67. ICC was calculated as 0.97 (0.95-0.98; p < 0.001), indicating a strong positive agreement between the test scores at two time points 2 weeks apart.
conclusionsThe Turkish version of IFCI-Q seems to be a reliable, consistent, and valid instrument in the screening and assessment of CI in a gynecology outpatient clinic-based cohort of Turkish-speaking women.
Indexed as
Identifiers
39804353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.